CHECKPOINT THERAPEUTICS INC revenue breakdown overview

CHECKPOINT THERAPEUTICS INC revenue for the last year amounted to 93.32 k EUR, the most of which — 93.32 k EUR — came from its highest performing source at the moment, Novel Treatments for Solid Tumor Cancers, the year earlier bringing 179.40 k EUR. The greatest contribution to the revenue figure was made by United States — last year it brought CHECKPOINT THERAPEUTICS INC 93.32 k EUR, and the year before that — 179.40 k EUR.